| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Non-Small-Cell Lung | 24 | 2023 | 341 | 5.460 |
Why?
|
| Lung Neoplasms | 40 | 2024 | 1543 | 5.370 |
Why?
|
| Esophageal Neoplasms | 15 | 2024 | 392 | 3.830 |
Why?
|
| Mesothelioma | 8 | 2024 | 93 | 3.190 |
Why?
|
| Pneumonectomy | 15 | 2022 | 147 | 2.800 |
Why?
|
| Esophagectomy | 10 | 2024 | 71 | 2.450 |
Why?
|
| Adenocarcinoma | 12 | 2024 | 986 | 2.160 |
Why?
|
| Neoplasm Staging | 29 | 2023 | 1300 | 2.050 |
Why?
|
| Pleural Neoplasms | 7 | 2025 | 82 | 1.950 |
Why?
|
| Small Cell Lung Carcinoma | 2 | 2023 | 32 | 1.520 |
Why?
|
| Lymphatic Metastasis | 14 | 2024 | 427 | 1.510 |
Why?
|
| Thoracic Surgical Procedures | 4 | 2020 | 105 | 1.410 |
Why?
|
| Lymph Nodes | 10 | 2017 | 360 | 1.280 |
Why?
|
| Neoadjuvant Therapy | 6 | 2022 | 394 | 1.180 |
Why?
|
| Esophageal Perforation | 4 | 2024 | 14 | 1.110 |
Why?
|
| Thoracoscopy | 4 | 2021 | 42 | 0.880 |
Why?
|
| Surgical Flaps | 3 | 2021 | 180 | 0.870 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2023 | 392 | 0.810 |
Why?
|
| SEER Program | 8 | 2019 | 211 | 0.810 |
Why?
|
| Neoplasm Grading | 2 | 2023 | 277 | 0.780 |
Why?
|
| Radiosurgery | 2 | 2022 | 146 | 0.770 |
Why?
|
| Humans | 104 | 2025 | 130422 | 0.750 |
Why?
|
| Bronchial Fistula | 4 | 2012 | 23 | 0.710 |
Why?
|
| Biopsy, Fine-Needle | 5 | 2012 | 107 | 0.700 |
Why?
|
| Hernia, Diaphragmatic | 3 | 2011 | 92 | 0.700 |
Why?
|
| Positron-Emission Tomography | 4 | 2020 | 293 | 0.700 |
Why?
|
| Pleural Diseases | 3 | 2009 | 31 | 0.690 |
Why?
|
| Funnel Chest | 1 | 2021 | 33 | 0.660 |
Why?
|
| Metastasectomy | 1 | 2020 | 11 | 0.660 |
Why?
|
| Respiratory Paralysis | 2 | 2010 | 6 | 0.640 |
Why?
|
| Endosonography | 3 | 2012 | 76 | 0.630 |
Why?
|
| Ketorolac | 1 | 2020 | 10 | 0.630 |
Why?
|
| Stomach | 1 | 2021 | 271 | 0.560 |
Why?
|
| Treatment Outcome | 26 | 2024 | 12860 | 0.560 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2019 | 103 | 0.560 |
Why?
|
| Health Services Research | 1 | 2019 | 178 | 0.560 |
Why?
|
| Databases, Factual | 3 | 2019 | 1223 | 0.550 |
Why?
|
| Venous Thrombosis | 1 | 2020 | 173 | 0.550 |
Why?
|
| Internship and Residency | 5 | 2021 | 1215 | 0.540 |
Why?
|
| Educational Measurement | 2 | 2020 | 317 | 0.540 |
Why?
|
| Surgeons | 3 | 2021 | 289 | 0.530 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2021 | 1276 | 0.520 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 193 | 0.510 |
Why?
|
| Certification | 1 | 2017 | 68 | 0.500 |
Why?
|
| Chemoradiotherapy | 1 | 2017 | 125 | 0.500 |
Why?
|
| Frailty | 1 | 2019 | 140 | 0.480 |
Why?
|
| Registries | 3 | 2019 | 1605 | 0.460 |
Why?
|
| Respiratory Function Tests | 9 | 2010 | 222 | 0.450 |
Why?
|
| Thoracic Surgery | 5 | 2019 | 162 | 0.450 |
Why?
|
| Postoperative Care | 3 | 2016 | 297 | 0.430 |
Why?
|
| Middle Aged | 49 | 2025 | 28383 | 0.430 |
Why?
|
| Laparoscopy | 4 | 2020 | 541 | 0.420 |
Why?
|
| Mediastinum | 9 | 2012 | 45 | 0.420 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2017 | 754 | 0.420 |
Why?
|
| Anastomotic Leak | 3 | 2021 | 36 | 0.410 |
Why?
|
| Aged | 39 | 2025 | 20894 | 0.400 |
Why?
|
| Mediastinoscopy | 3 | 2009 | 6 | 0.400 |
Why?
|
| Survival Rate | 13 | 2022 | 2131 | 0.390 |
Why?
|
| Pamphlets | 1 | 2013 | 22 | 0.390 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 692 | 0.380 |
Why?
|
| Socioeconomic Factors | 2 | 2021 | 889 | 0.380 |
Why?
|
| Health Communication | 1 | 2013 | 31 | 0.380 |
Why?
|
| Retrospective Studies | 29 | 2024 | 17614 | 0.370 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 1152 | 0.370 |
Why?
|
| Prognosis | 8 | 2024 | 4894 | 0.370 |
Why?
|
| Aged, 80 and over | 22 | 2020 | 6781 | 0.360 |
Why?
|
| Mammography | 1 | 2013 | 124 | 0.360 |
Why?
|
| Insurance, Health | 1 | 2013 | 139 | 0.360 |
Why?
|
| Insurance Coverage | 1 | 2013 | 116 | 0.360 |
Why?
|
| Ultrasonography, Interventional | 3 | 2016 | 212 | 0.340 |
Why?
|
| GPI-Linked Proteins | 2 | 2024 | 105 | 0.340 |
Why?
|
| Cisplatin | 4 | 2023 | 271 | 0.340 |
Why?
|
| Carcinoid Tumor | 1 | 2011 | 24 | 0.330 |
Why?
|
| Postoperative Complications | 8 | 2016 | 3112 | 0.330 |
Why?
|
| Male | 54 | 2025 | 64527 | 0.330 |
Why?
|
| Appendiceal Neoplasms | 1 | 2011 | 22 | 0.330 |
Why?
|
| Esophagoscopy | 4 | 2024 | 173 | 0.320 |
Why?
|
| Colectomy | 1 | 2011 | 90 | 0.320 |
Why?
|
| Appendectomy | 1 | 2011 | 88 | 0.320 |
Why?
|
| Thoracic Neoplasms | 1 | 2010 | 37 | 0.320 |
Why?
|
| Informed Consent | 1 | 2013 | 348 | 0.310 |
Why?
|
| Diaphragmatic Eventration | 1 | 2009 | 7 | 0.310 |
Why?
|
| Anastomosis, Surgical | 2 | 2021 | 175 | 0.310 |
Why?
|
| Respiratory Tract Fistula | 1 | 2009 | 16 | 0.310 |
Why?
|
| Female | 51 | 2025 | 70285 | 0.300 |
Why?
|
| Risk Factors | 9 | 2024 | 10942 | 0.300 |
Why?
|
| Smoking | 6 | 2008 | 923 | 0.300 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 646 | 0.290 |
Why?
|
| Melanoma | 2 | 2013 | 918 | 0.290 |
Why?
|
| Diaphragm | 1 | 2010 | 100 | 0.290 |
Why?
|
| Thymus Neoplasms | 2 | 2019 | 40 | 0.290 |
Why?
|
| Mediastinal Neoplasms | 1 | 2008 | 37 | 0.280 |
Why?
|
| Lung | 6 | 2022 | 1547 | 0.270 |
Why?
|
| Hernia, Diaphragmatic, Traumatic | 1 | 2008 | 6 | 0.270 |
Why?
|
| Predictive Value of Tests | 6 | 2024 | 2298 | 0.270 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 207 | 0.260 |
Why?
|
| Risk Assessment | 8 | 2021 | 3682 | 0.260 |
Why?
|
| Device Removal | 2 | 2010 | 225 | 0.250 |
Why?
|
| Mass Screening | 1 | 2013 | 805 | 0.250 |
Why?
|
| Clinical Competence | 3 | 2015 | 1051 | 0.250 |
Why?
|
| Health Status Disparities | 1 | 2010 | 275 | 0.240 |
Why?
|
| Quality of Life | 4 | 2022 | 2071 | 0.240 |
Why?
|
| Neoplasms | 1 | 2021 | 2944 | 0.240 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2011 | 2107 | 0.240 |
Why?
|
| Reoperation | 4 | 2021 | 832 | 0.230 |
Why?
|
| Chemoradiotherapy, Adjuvant | 2 | 2018 | 30 | 0.230 |
Why?
|
| United States | 12 | 2021 | 11827 | 0.220 |
Why?
|
| Drainage | 4 | 2016 | 248 | 0.220 |
Why?
|
| Healthcare Disparities | 1 | 2010 | 499 | 0.210 |
Why?
|
| Adult | 32 | 2021 | 31127 | 0.210 |
Why?
|
| Time Factors | 12 | 2018 | 6190 | 0.200 |
Why?
|
| Hospitals, High-Volume | 2 | 2021 | 43 | 0.200 |
Why?
|
| Career Choice | 2 | 2015 | 165 | 0.200 |
Why?
|
| Cytoreduction Surgical Procedures | 2 | 2022 | 51 | 0.200 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 1005 | 0.200 |
Why?
|
| Biomarkers, Tumor | 2 | 2024 | 1606 | 0.190 |
Why?
|
| Endoscopic Mucosal Resection | 2 | 2021 | 65 | 0.190 |
Why?
|
| Patient Selection | 4 | 2015 | 721 | 0.180 |
Why?
|
| Cardiovascular Diseases | 2 | 2015 | 2110 | 0.180 |
Why?
|
| Thoracic Surgery, Video-Assisted | 4 | 2009 | 56 | 0.180 |
Why?
|
| Survival Analysis | 5 | 2017 | 1498 | 0.170 |
Why?
|
| Sternum | 1 | 2021 | 50 | 0.170 |
Why?
|
| Heart Transplantation | 1 | 2008 | 824 | 0.170 |
Why?
|
| Esophageal Motility Disorders | 1 | 2020 | 19 | 0.160 |
Why?
|
| Myotomy | 1 | 2020 | 16 | 0.160 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 2603 | 0.160 |
Why?
|
| Regional Blood Flow | 1 | 2021 | 192 | 0.160 |
Why?
|
| Genetic Therapy | 1 | 2025 | 718 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 810 | 0.160 |
Why?
|
| Surveys and Questionnaires | 5 | 2015 | 4002 | 0.160 |
Why?
|
| Health Services Accessibility | 2 | 2019 | 693 | 0.150 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 7 | 0.150 |
Why?
|
| Thymectomy | 1 | 2019 | 23 | 0.150 |
Why?
|
| Immunotherapy | 1 | 2024 | 753 | 0.150 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2019 | 86 | 0.150 |
Why?
|
| Thymoma | 1 | 2019 | 21 | 0.150 |
Why?
|
| Heart-Assist Devices | 1 | 2008 | 992 | 0.150 |
Why?
|
| Margins of Excision | 1 | 2019 | 54 | 0.140 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2019 | 81 | 0.140 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2019 | 44 | 0.140 |
Why?
|
| Intention | 1 | 2019 | 101 | 0.140 |
Why?
|
| Attention | 1 | 2020 | 192 | 0.140 |
Why?
|
| Thoracotomy | 2 | 2008 | 108 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2023 | 1312 | 0.130 |
Why?
|
| Robotics | 1 | 2019 | 102 | 0.130 |
Why?
|
| Tumor Burden | 2 | 2015 | 239 | 0.130 |
Why?
|
| Blood Transfusion | 1 | 2019 | 291 | 0.130 |
Why?
|
| Neoplasm, Residual | 1 | 2017 | 132 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 3815 | 0.120 |
Why?
|
| Follow-Up Studies | 10 | 2019 | 5186 | 0.120 |
Why?
|
| Lymph Node Excision | 3 | 2012 | 160 | 0.120 |
Why?
|
| Population Surveillance | 2 | 2016 | 396 | 0.120 |
Why?
|
| Ascites | 1 | 2016 | 98 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2011 | 1076 | 0.120 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1925 | 0.120 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2015 | 12 | 0.120 |
Why?
|
| Pancreatectomy | 1 | 2016 | 147 | 0.120 |
Why?
|
| Esophagogastric Junction | 2 | 2020 | 36 | 0.110 |
Why?
|
| Respiration Disorders | 1 | 2015 | 31 | 0.110 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 2 | 2011 | 10 | 0.110 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 680 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 3 | 2017 | 628 | 0.110 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 1994 | 2 | 0.110 |
Why?
|
| Mucociliary Clearance | 1 | 1994 | 6 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 2106 | 0.110 |
Why?
|
| Bronchoscopy | 3 | 2010 | 177 | 0.110 |
Why?
|
| Stomach Neoplasms | 2 | 2012 | 576 | 0.110 |
Why?
|
| Endoscopy | 1 | 2016 | 270 | 0.110 |
Why?
|
| Morbidity | 1 | 2015 | 259 | 0.110 |
Why?
|
| Cohort Studies | 7 | 2022 | 5069 | 0.110 |
Why?
|
| Hematologic Diseases | 1 | 2015 | 82 | 0.110 |
Why?
|
| Probability | 3 | 2009 | 306 | 0.100 |
Why?
|
| Odds Ratio | 3 | 2013 | 1215 | 0.100 |
Why?
|
| Austria | 1 | 2013 | 21 | 0.100 |
Why?
|
| Confidence Intervals | 2 | 2013 | 269 | 0.100 |
Why?
|
| Empyema, Pleural | 2 | 2009 | 26 | 0.100 |
Why?
|
| Esophageal Fistula | 1 | 2012 | 15 | 0.090 |
Why?
|
| Bronchi | 1 | 2012 | 98 | 0.090 |
Why?
|
| Health Literacy | 1 | 2013 | 75 | 0.090 |
Why?
|
| Barrett Esophagus | 1 | 2016 | 360 | 0.090 |
Why?
|
| Carcinoma, Small Cell | 6 | 2008 | 38 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2019 | 2476 | 0.090 |
Why?
|
| Young Adult | 5 | 2019 | 9995 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 200 | 0.090 |
Why?
|
| Respiration | 3 | 1989 | 119 | 0.090 |
Why?
|
| Disease Management | 1 | 2015 | 559 | 0.090 |
Why?
|
| Emergencies | 1 | 2012 | 176 | 0.090 |
Why?
|
| Ultrasonography | 3 | 2010 | 963 | 0.080 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2010 | 16 | 0.080 |
Why?
|
| Information Dissemination | 1 | 2013 | 195 | 0.080 |
Why?
|
| Pharyngostomy | 1 | 2010 | 2 | 0.080 |
Why?
|
| Incidence | 2 | 2008 | 3330 | 0.080 |
Why?
|
| Medicaid | 1 | 2013 | 251 | 0.080 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2012 | 226 | 0.080 |
Why?
|
| Spinal Fractures | 1 | 2010 | 50 | 0.080 |
Why?
|
| Education, Medical, Graduate | 2 | 2021 | 551 | 0.080 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2010 | 52 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2013 | 391 | 0.080 |
Why?
|
| Rheumatoid Nodule | 1 | 2009 | 2 | 0.080 |
Why?
|
| Hospital Mortality | 2 | 2012 | 1065 | 0.080 |
Why?
|
| Carcinoma | 1 | 2012 | 284 | 0.080 |
Why?
|
| Cervical Vertebrae | 1 | 2010 | 117 | 0.080 |
Why?
|
| Decompression, Surgical | 1 | 2010 | 89 | 0.080 |
Why?
|
| Medicare | 1 | 2013 | 438 | 0.080 |
Why?
|
| Orthopedic Procedures | 1 | 2010 | 82 | 0.080 |
Why?
|
| Cardia | 1 | 2009 | 26 | 0.080 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2009 | 30 | 0.070 |
Why?
|
| Health Promotion | 1 | 2013 | 408 | 0.070 |
Why?
|
| Sympathectomy | 1 | 2009 | 8 | 0.070 |
Why?
|
| Fistula | 1 | 2009 | 49 | 0.070 |
Why?
|
| Hyperhidrosis | 1 | 2009 | 8 | 0.070 |
Why?
|
| Stents | 2 | 2012 | 780 | 0.070 |
Why?
|
| Physicians | 1 | 2015 | 634 | 0.070 |
Why?
|
| Esophagus | 1 | 2010 | 233 | 0.070 |
Why?
|
| Pleural Effusion | 1 | 2009 | 106 | 0.070 |
Why?
|
| Pneumothorax | 1 | 2009 | 79 | 0.070 |
Why?
|
| Suture Techniques | 1 | 2009 | 175 | 0.070 |
Why?
|
| Disease-Free Survival | 4 | 2011 | 900 | 0.070 |
Why?
|
| Immunity, Cellular | 1 | 2008 | 191 | 0.070 |
Why?
|
| Fibrosis | 1 | 2009 | 419 | 0.070 |
Why?
|
| Polytetrafluoroethylene | 1 | 2008 | 61 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 130 | 0.070 |
Why?
|
| Surgical Procedures, Operative | 1 | 2010 | 224 | 0.070 |
Why?
|
| Carcinosarcoma | 1 | 2007 | 11 | 0.070 |
Why?
|
| Radiography | 1 | 2009 | 749 | 0.070 |
Why?
|
| Biocompatible Materials | 1 | 2008 | 108 | 0.060 |
Why?
|
| Sphincterotomy, Endoscopic | 1 | 2006 | 11 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 2008 | 191 | 0.060 |
Why?
|
| Bile Ducts | 1 | 2006 | 52 | 0.060 |
Why?
|
| Adolescent | 5 | 2019 | 20754 | 0.060 |
Why?
|
| Quality of Health Care | 1 | 2010 | 406 | 0.060 |
Why?
|
| Minnesota | 3 | 2011 | 178 | 0.060 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2009 | 283 | 0.060 |
Why?
|
| Uterine Neoplasms | 1 | 2007 | 101 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2008 | 222 | 0.060 |
Why?
|
| Equipment Design | 1 | 2008 | 541 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2008 | 1258 | 0.060 |
Why?
|
| General Surgery | 1 | 2008 | 225 | 0.060 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2006 | 230 | 0.060 |
Why?
|
| Reference Values | 3 | 2009 | 678 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 3715 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 495 | 0.050 |
Why?
|
| Comorbidity | 3 | 2016 | 1587 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2008 | 420 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2024 | 129 | 0.050 |
Why?
|
| Age Factors | 4 | 2012 | 2835 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 907 | 0.050 |
Why?
|
| Proportional Hazards Models | 3 | 2011 | 1399 | 0.050 |
Why?
|
| Cytokines | 1 | 2008 | 1335 | 0.050 |
Why?
|
| Curriculum | 1 | 2008 | 784 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2010 | 899 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2006 | 765 | 0.040 |
Why?
|
| Sex Factors | 3 | 2012 | 1334 | 0.040 |
Why?
|
| Accreditation | 1 | 2021 | 87 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2025 | 622 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2022 | 308 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 698 | 0.040 |
Why?
|
| Prospective Studies | 5 | 2016 | 6423 | 0.040 |
Why?
|
| Manometry | 1 | 2020 | 73 | 0.040 |
Why?
|
| Hospitals, Low-Volume | 1 | 2019 | 35 | 0.040 |
Why?
|
| Bleomycin | 2 | 1989 | 118 | 0.040 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2019 | 70 | 0.040 |
Why?
|
| Radionuclide Imaging | 3 | 1994 | 114 | 0.030 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 1989 | 93 | 0.030 |
Why?
|
| Solubility | 1 | 2017 | 117 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 1377 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 1233 | 0.030 |
Why?
|
| Chromium Radioisotopes | 1 | 1997 | 2 | 0.030 |
Why?
|
| Edetic Acid | 1 | 1997 | 25 | 0.030 |
Why?
|
| Iohexol | 1 | 1997 | 19 | 0.030 |
Why?
|
| Germany | 1 | 2016 | 57 | 0.030 |
Why?
|
| Causality | 1 | 2016 | 90 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2016 | 49 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1452 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 606 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 339 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 372 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2011 | 1485 | 0.030 |
Why?
|
| Employment | 1 | 2015 | 72 | 0.030 |
Why?
|
| Terbutaline | 1 | 1994 | 7 | 0.030 |
Why?
|
| Ventilation-Perfusion Ratio | 2 | 1985 | 6 | 0.030 |
Why?
|
| Job Satisfaction | 1 | 2015 | 100 | 0.030 |
Why?
|
| Aerosols | 1 | 1994 | 58 | 0.030 |
Why?
|
| Peptides | 1 | 2017 | 708 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1291 | 0.030 |
Why?
|
| Algorithms | 2 | 2011 | 1680 | 0.030 |
Why?
|
| Forecasting | 1 | 2015 | 353 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 528 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 1215 | 0.020 |
Why?
|
| Contrast Media | 1 | 1997 | 491 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 706 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2016 | 320 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2012 | 87 | 0.020 |
Why?
|
| Linear Models | 1 | 1994 | 688 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 416 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1607 | 0.020 |
Why?
|
| Vascular Fistula | 1 | 2012 | 27 | 0.020 |
Why?
|
| Apoptosis | 1 | 2019 | 1842 | 0.020 |
Why?
|
| Vinblastine | 2 | 1989 | 54 | 0.020 |
Why?
|
| Gastrectomy | 1 | 2012 | 106 | 0.020 |
Why?
|
| Apgar Score | 1 | 2011 | 50 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 561 | 0.020 |
Why?
|
| Debridement | 1 | 2010 | 87 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 2012 | 188 | 0.020 |
Why?
|
| Critical Pathways | 1 | 2011 | 77 | 0.020 |
Why?
|
| Plants, Toxic | 1 | 1989 | 6 | 0.020 |
Why?
|
| Logistic Models | 2 | 2012 | 1799 | 0.020 |
Why?
|
| Mucus | 1 | 1989 | 37 | 0.020 |
Why?
|
| Vital Capacity | 1 | 1990 | 90 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2011 | 228 | 0.020 |
Why?
|
| Pleurodesis | 1 | 2009 | 15 | 0.020 |
Why?
|
| Pentetic Acid | 1 | 1989 | 7 | 0.020 |
Why?
|
| Technetium | 1 | 1989 | 15 | 0.020 |
Why?
|
| Chest Tubes | 1 | 2009 | 38 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 2685 | 0.020 |
Why?
|
| Abscess | 1 | 2010 | 136 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 1990 | 177 | 0.020 |
Why?
|
| Birth Weight | 1 | 2011 | 341 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2010 | 147 | 0.020 |
Why?
|
| Cause of Death | 1 | 2011 | 503 | 0.020 |
Why?
|
| Blastomycosis | 1 | 2008 | 6 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 266 | 0.020 |
Why?
|
| Regression Analysis | 2 | 1990 | 759 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1239 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2009 | 351 | 0.020 |
Why?
|
| Online Systems | 1 | 2008 | 17 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2008 | 35 | 0.020 |
Why?
|
| Mice | 1 | 2025 | 18188 | 0.020 |
Why?
|
| PubMed | 1 | 2008 | 21 | 0.020 |
Why?
|
| Health Planning Guidelines | 1 | 2008 | 33 | 0.020 |
Why?
|
| Osteomyelitis | 1 | 2010 | 210 | 0.020 |
Why?
|
| Computer-Assisted Instruction | 1 | 2008 | 58 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 1988 | 111 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 1994 | 2919 | 0.020 |
Why?
|
| Wound Healing | 1 | 2011 | 476 | 0.020 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2008 | 160 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2007 | 143 | 0.020 |
Why?
|
| Gestational Age | 1 | 2011 | 1212 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2009 | 358 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2008 | 342 | 0.020 |
Why?
|
| Mathematics | 1 | 1986 | 71 | 0.020 |
Why?
|
| Computers | 1 | 1986 | 67 | 0.010 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2011 | 400 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 2011 | 449 | 0.010 |
Why?
|
| Recurrence | 1 | 2009 | 1482 | 0.010 |
Why?
|
| Catheterization | 1 | 2006 | 226 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2009 | 451 | 0.010 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2012 | 744 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2008 | 401 | 0.010 |
Why?
|
| Animals | 1 | 2025 | 33892 | 0.010 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2011 | 675 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1988 | 1337 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1990 | 890 | 0.010 |
Why?
|
| Kidney | 1 | 1988 | 1283 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 3388 | 0.010 |
Why?
|
| Models, Biological | 1 | 1986 | 1390 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 3033 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 1710 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 2 | 1997 | 569 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2008 | 1005 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 3394 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2011 | 1875 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 2546 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8493 | 0.010 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 1997 | 1 | 0.010 |
Why?
|
| Scintillation Counting | 1 | 1997 | 8 | 0.010 |
Why?
|
| Urography | 1 | 1997 | 20 | 0.010 |
Why?
|
| Lung Volume Measurements | 2 | 1987 | 74 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1997 | 132 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1997 | 238 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1983 | 1796 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1985 | 1164 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2006 | 14985 | 0.010 |
Why?
|
| Random Allocation | 1 | 1989 | 416 | 0.000 |
Why?
|
| Educational Status | 1 | 1989 | 274 | 0.000 |
Why?
|
| Alcohol Drinking | 1 | 1989 | 343 | 0.000 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1987 | 34 | 0.000 |
Why?
|
| Creatinine | 1 | 1988 | 398 | 0.000 |
Why?
|
| Remission Induction | 1 | 1987 | 301 | 0.000 |
Why?
|
| Child | 1 | 2006 | 26165 | 0.000 |
Why?
|
| Body Weight | 1 | 1990 | 984 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1990 | 1106 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1989 | 1231 | 0.000 |
Why?
|